{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T17:47:34Z","timestamp":1778953654720,"version":"3.51.4"},"reference-count":30,"publisher":"American Society for Microbiology","issue":"2","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2006,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>Anthrax toxin consists of protective antigen (PA) and two toxic components, lethal factor (LF) and edema factor (EF). PA binds to mammalian cellular receptors and delivers the toxic components to the cytoplasm. PA is the primary antigenic component of the current anthrax vaccine. Immunity is due to the generation of antibodies that prevent the PA-mediated internalization of LF and EF. In this study, we characterized sera obtained from vaccinated military personnel. Anthrax vaccine is administered in a series of six injections at 0, 2, and 4 weeks and 6, 12, and 18 months, followed by annual boosters. The vaccination histories of the subjects were highly varied; many subjects had not completed the entire series, and several had not received annual boosters. We developed a simple colorimetric assay using alamarBlue dye to assess the antibody-mediated neutralization of LF-mediated toxicity to the J774A.1 murine macrophage cell line. Recently vaccinated individuals had high antibody levels and neutralizing activity. One individual who had not been boosted for 5 years had low immunoglobulin G antibody levels but a detectable neutralization activity, suggesting that this individual produced low levels of very active antibodies.<\/jats:p>","DOI":"10.1128\/cvi.13.2.208-213.2006","type":"journal-article","created":{"date-parts":[[2006,2,8]],"date-time":"2006-02-08T07:07:43Z","timestamp":1139382463000},"page":"208-213","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":19,"title":["Neutralizing Antibodies and Persistence of Immunity following Anthrax Vaccination"],"prefix":"10.1128","volume":"13","author":[{"given":"James F.","family":"Hanson","sequence":"first","affiliation":[{"name":"Department of Molecular Genetics, Biochemistry, and Microbiology, University of Cincinnati, 231 Albert Sabin Way, Cincinnati, Ohio 45267-0524"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah C.","family":"Taft","sequence":"additional","affiliation":[{"name":"Department of Molecular Genetics, Biochemistry, and Microbiology, University of Cincinnati, 231 Albert Sabin Way, Cincinnati, Ohio 45267-0524"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison A.","family":"Weiss","sequence":"additional","affiliation":[{"name":"Department of Molecular Genetics, Biochemistry, and Microbiology, University of Cincinnati, 231 Albert Sabin Way, Cincinnati, Ohio 45267-0524"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nature01794","volume":"424","year":"2003","unstructured":"Agrawal, A., J. Lingappa, S. H. Leppla, S. Agrawal, A. Jabbar, C. Quinn, and B. Pulendran. 2003. Impairment of dendritic cells and adaptive immunity by anthrax lethal toxin. Nature424:329-334.","journal-title":"Nature"},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0022-1759(94)90396-4","volume":"170","year":"1994","unstructured":"Ahmed, S. A., R. M. Gogal, Jr., and J. E. Walsh. 1994. A new rapid and simple nonradioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay. J. Immunol. Methods170:211-224.","journal-title":"J. Immunol. Methods"},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"632","DOI":"10.2105\/AJPH.52.4.632","volume":"52","year":"1962","unstructured":"Brachman, P. S., H. Gold, S. A. Plotkin, F. R. Fekety, M. Werrin, and N. R. Ingraham. 1962. Field evaluation of a human anthrax vaccine. Am. J. Public Health52:632-645.","journal-title":"Am. J. Public Health"},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/n35101999","volume":"414","year":"2001","unstructured":"Bradley, K. A., J. Mogridge, M. Mourez, R. J. Collier, and J. A. Young. 2001. Identification of the cellular receptor for anthrax toxin. Nature414:225-229.","journal-title":"Nature"},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/S0041-0101(01)00161-1","volume":"39","year":"2001","unstructured":"Brossier, F., and M. Mock. 2001. Toxins of Bacillus anthracis. Toxicon39:1747-1755.","journal-title":"Toxicon"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.67.6.2957-2963.1999"},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.cellbio.19.111301.140655","volume":"19","year":"2003","unstructured":"Collier, R. J., and J. A. Young. 2003. Anthrax toxin. Annu. Rev. Cell Dev. Biol.19:45-70.","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.56.5.1066-1069.1988"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1091\/mbc.3.11.1269","volume":"3","year":"1992","unstructured":"Hanna, P. C., S. Kochi, and R. J. Collier. 1992. Biochemical and physiological changes induced by anthrax lethal toxin in J774 macrophage-like cells. Mol. Biol. Cell3:1269-1277.","journal-title":"Mol. Biol. Cell"},{"key":"e_1_3_2_11_2","unstructured":"Hanson J. F. 2004. Characterization of neutralizing responses to anthrax toxin and isolation and characterization of the Shiga-toxin encoding phage from Escherichia coli O157:H7. M.S. thesis. University of Cincinnati Cincinnati Ohio."},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0264-410X(98)80112-6","volume":"16","year":"1998","unstructured":"Ivins, B. E., M. L. Pitt, P. F. Fellows, J. W. Farchaus, G. E. Benner, D. M. Waag, S. F. Little, G. W. Anderson, Jr., P. H. Gibbs, and A. M. Friedlander. 1998. Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques. Vaccine16:1141-1148.","journal-title":"Vaccine"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.72.1.430-439.2004"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.9.4997-5007.2002"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1172\/JCI0216204","volume":"110","year":"2002","unstructured":"Leppla, S. H., J. B. Robbins, R. Schneerson, and J. Shiloach. 2002. Development of an improved vaccine for anthrax. J. Clin. Investig.110:141-144.","journal-title":"J. Clin. Investig."},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.65.12.5171-5175.1997"},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nbt0602-597","volume":"20","year":"2002","unstructured":"Maynard, J. A., C. B. Maassen, S. H. Leppla, K. Brasky, J. L. Patterson, B. L. Iverson, and G. Georgiou. 2002. Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity. Nat. Biotechnol.20:597-601.","journal-title":"Nat. Biotechnol."},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.72.1.615-620.2004"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.72.6.3276-3283.2004"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.47.1.306-310.1985"},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"5421","DOI":"10.1046\/j.1432-1327.2000.01606.x","volume":"267","year":"2000","unstructured":"O'Brien, J., I. Wilson, T. Orton, and F. Pognan. 2000. Investigation of the Alamar blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur. J. Biochem.267:5421-5426.","journal-title":"Eur. J. Biochem."},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/385833a0","volume":"385","year":"1997","unstructured":"Petosa, C., R. J. Collier, K. R. Klimpel, S. H. Leppla, and R. C. Liddington. 1997. Crystal structure of the anthrax toxin protective antigen. Nature385:833-838.","journal-title":"Nature"},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1046\/j.1365-2672.1999.00897.x","volume":"87","year":"1999","unstructured":"Pitt, M. L., S. Little, B. E. Ivins, P. Fellows, J. Boles, J. Barth, J. Hewetson, and A. M. Friedlander. 1999. In vitro correlate of immunity in an animal model of inhalational anthrax. J. Appl. Microbiol.87:304.","journal-title":"J. Appl. Microbiol."},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1016\/S0264-410X(01)00234-1","volume":"19","year":"2001","unstructured":"Pitt, M. L., S. F. Little, B. E. Ivins, P. Fellows, J. Barth, J. Hewetson, P. Gibbs, M. Dertzbaugh, and A. M. Friedlander. 2001. In vitro correlate of immunity in a rabbit model of inhalational anthrax. Vaccine19:4768-4773.","journal-title":"Vaccine"},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1476-8518-2-5","volume":"2","year":"2004","unstructured":"Sawada-Hirai, R., I. Jiang, F. Wang, S. M. Sun, R. Nedellec, P. Ruther, A. Alvarez, D. Millis, P. R. Morrow, and A. S. Kang. 2004. Human antianthrax protective antigen neutralizing monoclonal antibodies derived from donors vaccinated with anthrax vaccine adsorbed. J. Immune Based Ther. Vaccines2:5.","journal-title":"J. Immune Based Ther. Vaccines"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.12.7635-7641.2001"},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"5170","DOI":"10.1073\/pnas.0431098100","volume":"100","year":"2003","unstructured":"Scobie, H. M., G. J. Rainey, K. A. Bradley, and J. A. Young. 2003. Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor. Proc. Natl. Acad. Sci. USA100:5170-5174.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0264-410X(91)90237-Z","volume":"9","year":"1991","unstructured":"Turnbull, P. C. 1991. Anthrax vaccines: past, present and future. Vaccine9:533-539.","journal-title":"Vaccine"},{"key":"e_1_3_2_29_2","first-page":"105","volume":"13","year":"2004","unstructured":"Wang, F., P. Ruther, I. Jiang, R. Sawada-Hirai, S. M. Sun, R. Nedellec, P. R. Morrow, and A. S. Kang. 2004. Human monoclonal antibodies that neutralize anthrax toxin by inhibiting heptamer assembly. Hum. Antib.13:105-110.","journal-title":"Hum. Antib."},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.67.8.4264-4267.1999"},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/nbt891","volume":"21","year":"2003","unstructured":"Wild, M. A., H. Xin, T. Maruyama, M. J. Nolan, P. M. Calveley, J. D. Malone, M. R. Wallace, and K. S. Bowdish. 2003. Human antibodies from immunized donors are protective against anthrax toxin in vivo. Nat. Biotechnol.21:1305-1306.","journal-title":"Nat. Biotechnol."}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.13.2.208-213.2006","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.13.2.208-213.2006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T15:54:00Z","timestamp":1627574040000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.13.2.208-213.2006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["10.1128\/CVI.13.2.208-213.2006"],"URL":"https:\/\/doi.org\/10.1128\/cvi.13.2.208-213.2006","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,2]]},"assertion":[{"value":"2005-11-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-12-01","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}